U.S. Cellular's stock climbed 11% midday Friday. "U.S. Cellular Shares Climb 14% on Deals for Spectrum Assets," at 11:17 a.m. ET, misstated the percentage change in the headline.
Researchers in biomedical engineering will use the NIH award to conduct an in-depth analysis of the genetic and cellular determinants of gene therapy longevity.